The next board meeting for Myriad Genetics, Inc. is on 10 Sep 2025 for the purpose of The Morgan Stanley Annual Global Healthcare ConferenceSee details
Myriad Genetics, Inc. - MYGN - stock price prediction, stock price target, analyst ratings from 14 analysts
Myriad Genetics, Inc. has a share price target of US$ 7, revenue growth forecast of -1.8%, and profit growth estimate of -189.3% for FY25, based on top 14 analyst calls.